Editorial
COVID-19 treatment: High time for Antimicrobial Stewardship Program
Nenad Pandak
orcid.org/0000-0002-4379-6219
; Medicine Department, Infectious Disease Unit, Royal Hospital, Muscat, Oman
Vladimir Krajinović
; Department of Intensive Care Medicine and Neuroinfectology, University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Zagreb, Croatia
Abstract
Last several months, the World is witnessing Coronavirus disease 2019 (COVID-19) pandemic caused by the newly identified Coronavirus. Due to the fast and easy disease spread as well as its severity, currently this pandemic is dominating every aspect of the global healthcare systems but also it outstandingly influences every side of our lives including the global economy. Almost all COVID-19 treatment guidelines advocate the rational use of antibiotics, but if we analyse the reports published so far, it is evident that about 70% up to even 100% of patients are treated with antibiotics. This antibiotic misuse highlights the urgent need for launching the Antimicrobial Stewardship Program in order to monitor the appropriate use of antibiotics. In this article, the authors suggest the postulates for implementing the antibiotic stewardship in COVID-19 patients.
Keywords
COVID-19; antibiotics; Antibiotic Stewardship Program
Hrčak ID:
252501
URI
Publication date:
22.2.2021.
Visits: 1.906 *